Ta. Welborn et al., AUSTRALIAN DIABETES SCREENING STUDY - IMPAIRED GLUCOSE-TOLERANCE AND NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Metabolism, clinical and experimental, 46(12), 1997, pp. 35-39
In preventing non-insulin-dependent diabetes mellitus (NIDDM) and its
complications, screening high-risk individuals complements public heal
th measures. Our screening instrument for patients of general practiti
oners was a questionnaire for self-determined high-risk groups plus a
laboratory measurement of a random venous plasma glucose level. Collab
orating practitioners evaluated 100 consecutive outpatients aged 40 ye
ars or older. The questionnaire identified patients with two or more d
iabetic symptoms or with two or more risk factors, and they were recom
mended to have their blood tested. For those with a random plasma gluc
ose greater than 5.5 mmol/L, oral glucose tolerance tests (OGTTs) were
advised. Of 50,859 subjects completing the study, there were 1,013 ca
ses (2.0%) of new diabetes, 1,704 cases (3.4%) of impaired glucose tol
erance (IGT), end 5,508 cases (10.8%) of previously diagnosed diabetes
. Symptoms alone were a relatively poor discriminant. Almost all newly
identified NIDDM and IGT patients had two or more risk factors for NI
DDM. The risk ratios for abnormal glucose tolerance were as follows: h
igh blood pressure, 2.4; overweight, 2.0; and positive family history,
1.7. Selection of cutoff points higher than 5.5 mmol/L would have sub
stantially reduced the rate of newly discovered NIDDM and IGT. Screeni
ng for NIDDM and IGT in general practice is feasible and can be achiev
ed with little disruption of office procedures. In preventive programs
of this nature, the low screening threshold of 5.5 mmol/L for random
venous plasma glucose maximizes the case-finding rate. Copyright (C) 1
997 by W.B. Saunders Company.